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 Pharmacy 553 Pharm.D.:  Therapeutics III Fall 2001 
 
Lectures:   M-W-F 1110-1200 Skaggs Bldg Rm 117 
  F only  1010-1100      “           Rm 114 
 
Course Coordinator: Michael Rivey  ====>  M. Rivey 
Instructors:   Douglas Allington         Office:  243-6796 
    Rose Macklin      Community Hosp: 327-4299 
    Cathy Bartels                 ext. 7605 
    Sarah Miller               Pager: 329-6122 
    Gayle Cochran   Home: 251-3369 
    Donna Beall 
    Lee Ann Bradley 
     
Material and Resources 
 Required Texts: DiPiro Pharmacotherapy, 4th edition 
APhA:  Handbook of Nonprescription Drugs 
    Medical Letter on Drugs & Therapeutics 
    Goodman & Gilman's Pharmacological Basis of Therapeutics 
    Boh Pharmacy Practice Manual 
    A medical dictionary 
 
 Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference 
    Evans:  Applied Pharmacokinetics 
    Young, Koda-Kimble:  Applied Therapeutics 
    Herfindal, Gourley, Hart:  Clinical Pharmacy and Therapeutics 
    Hansten & Horn:  Drug Interactions 
    Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text 
      
Goals of the Course 
 
 To promote the students' understanding of common disease 
 states with particular emphasis on the facets of diseases 
 that are amenable to drug therapy. 
 
 To familiarize the student with the proper use of drugs in 
 a clinical setting. 
  
 To develop the students' awareness of factors that should be 
 considered prior to selection of a drug and the appropriate 
 parameters that should be monitored for therapeutic as well 
 as undesired effects. 
 
 To encourage the students' ability to problem-solve in the 
 clinical setting. 
 
 
Performance Objectives 
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 Upon completion of this course, each student shall be able to: 
 
 Relate the pathophysiology of a disease to the known or purported action of a drug. 
 
Evaluate the seriousness of a disorder based on the signs and symptoms related to a 
diagnosed problem, and: 
  --determine the necessity of drug therapy, 
  --when applicable, choose the proper drug and/or 
   drug product for the situation. 
 
 Determine the place of non-pharmacologic and natural therapies, when applicable. 
 
Tailor the drug therapy of an individual based on patient characteristics and known 
pharmacokinetics principles. 
 
 Identify potential drug-drug interactions. 
 
 Monitor the appropriate parameters of a disease to determine if the patient is responding 
positively to therapy. 
 
Monitor for adverse drug reactions and exacerbations of underlying patient problems 
resulting from drug therapy. 
 
Student Responsibilities and Obligations 
 
 * To attend and participate in lecture sessions. 
 
 * To do assigned readings from the texts. 
 
* To attend Integrated Studies conferences, prepare each case in advance, to present a 
patient case, and participate in the discussion of all patient presentations. 
 
 * To perform satisfactorily on course quizzes and lecture examinations.   
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GRADING IN COURSE:  Phar 553 Therapeutics III 
 
3 midterm exams: 100 points each                       300 points  
Final exam (comprehensive, multiple choice)                  130 points 
(100 pts comprehensive, 30 pts over last 6 lectures) 
Topic quizzes:  8 quizzes graded on 10 pts each   Bonus pts > 75% 
TOTAL POINTS FOR COURSE                                430 POINTS 
 
Class quizzes:  The purposes of the quizzes are to promote reading of the text before a topic 
and encourage class attendance and attention.  Quizzes will occur before topic lectures and will 
test understanding of basic concepts in the reading assignment, and will cover only 
chapter/reading material associated with the day the quiz is scheduled. A quiz will consist of 5 
multiple choice or true/false questions, each worth 2 points.  QUIZ on syllabus indicates a quiz 
will be given for assigned reading at start of the given lecture.  Lowest 2 quiz grades will be 
thrown out; no make-ups will be allowed for quiz.  Scoring:  Quiz performance can only 
benefit student; bonus points for the course will be awarded for all points over 75% (i.e. 60 pts) 
of the potential total 80 pts on the quizzes (10 total quizzes – 2 throw-outs = 8x10 pts) 
 
NOTE:  Reading assignments are from DiPiro (4th edition) & APhA books 
 
Integrated Studies Conferences: you will be assigned to a conference based on period you 
registered for; instructors are not necessarily the ones under which you registered.  
Attendance/make-up is required for all topics/cases; you may attend a different conference in 
order to complete the assignment, but ONLY with instructor permission.  The “make-up” 
requirement for a conference missed due to unavoidable incident will be at the discretion of the 
instructor, dependent on the topic.  Failure to complete any conference will result in a grade of 
“fail” for course. 
 
Exams: 
3 midterm exams:  Tests will be in "traditional" case report fashion with short answers required. 
 Tests will be given during a “common” time period.  B.S. and Pharm.D. classes will take tests 
simultaneously.   
 
Final exam:  65 multiple choice questions worth 2 pts each.  Effort will be made to design 
questions in the style similar to the NAPLEX exam. 
 
Class civility:  Your student colleagues have strongly indicated to us that they wish to spend 
their valuable time in class listening to therapeutics topics.  They do not appreciate any “side” 
conversations while the instructor is lecturing.  They do appreciate students raising questions 
about important lecture aspects for further discussion or clarification.   
 Out of respect for your classmates, we will not tolerate excessive and disruptive talking 
during lecture.  The instructor may first ask you to be silent; you may be asked to leave class if 
you persist in disruptive talking.  The instructor will be the judge of “what” constitutes disruption. 
 Please note that we encourage questions and relevant discussion. 
   Therapeutics 553 Pharm.D.: Lecture Syllabus 
* denotes “early” 1010-1100 Friday lecture; “joint” denotes B.S. class will join 
        Instructor Reading 
Sept  5W Introduction/ Liver disease  MPR   
  7F* Renal disease/ joint/ QUIZ DRA  40 
  7F Liver disease    MPR  38   
 
 10M Liver Disease    MPR  35 
 12W Renal disease    DRA  41 
 14F* Pain Management/ joint   LAB  56 
 14F Renal disease    DRA  42 
 
 17M Pain mgmt/ joint    LAB 
 19W Headache/ joint/ QUIZ   DB  57 
 21F*  Headache/ joint    DB  OTC 3 
 21F Nausea & vomiting    LAB  33, OTC 5 
 
 24M N&V, emetics    LAB  OTC 25 
 25T Career Fair 
 26W Oncology     CLB  DiPiro pp. 1957-71 
 28F* Oncology     CLB  pp. 2002-7 
 28F Oncology     CLB  pp. 2013-41 
  
Oct  1M Oncology     CLB  pp. 2046-57 
  3W Arthritis / joint/ QUIZ   MPR  84 
  5F* Arthritis     MPR  83   
  5F Arthritis/ joint    MPR  OTC pp71-74,OTC 5 
  5F  Test 1 at 1-3 PM in SB ; through Oncology 
  
  8M Gout/ joint     MPR  85 
 10W Systemic Lupus Erythematosus  LRM  80 
 12F* Contraception/ joint/ QUIZ  DB  OTC 8 
 12F Contraception    DB  76 
 
 15M Contraception    DB 
 17W Urinary disorders    DRA  OTC 44  
 19F* off, in lieu of test 1 
 19F off, in lieu of test 2 ASP-MRM in Seattle 
 
 22M Menopause/ joint/ QUIZ   GAC  78 
 24W Menopause/ joint    GAC   
 26F* Osteoporosis/ joint    GAC  82, OTC 419-20 
 26F off, in lieu of test 3 
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553-Ther III, continued 
 
Oct 29M Osteoporosis/ joint    GAC 
 31W Obstruct. Airways Dx/ joint/ QUIZ DRA  24 
Nov  2F* OAD/ joint     DRA  25, OTC 10 
  2F Theophylline kinetics   DRA  
  2F Test 2 at 1-3PM in SB114; through osteoporosis 
  
  5M Theophylline PK/respiratory equip DRA 
  7W Thromboembolic disease/ joint  MPR  17 
  9F* Stroke/ joint/ QUIZ    MPR  18 
  9F TED      MPR 
    
 12M Veterans Day 
 14W Peripheral Vascular Disease  MPR  20 
 16F* Fluid & electrolytes/ QUIZ  SJM  DiPiro pp. 890-902 
 16F F & E      SJM  pp. 902-16 
   
 19M F & E      SJM 
 21W OFF; TRAVEL DAY 
 22Th THANKSGIVING HOLIDAY 
 23F  “ “ 
   
 26M Nutrition support    SJM  128 
 28W Nutrition support    SJM  129 
 30F* Nutrition support    SJM   
 30F Nutrition support    SJM 
   
Dec  3M Diabetes mellitus/ QUIZ   LRM  70 
  5W DM      LRM   
  7F* DM      LRM   
  7F DM      LRM 
  7F test 3 at 1-3 PM in SB 114; through nutrition support 
  
 10M DM diet/tests    LRM  OTC 39 
 12W CLASS EVAL/ Thyroid dx/QUIZ  MPR  71 
 14F* Thyroid disorders/    MPR   
 14F Thyroid dx     MPR 
 
Final:  test 4, 130 pts comprehensive multiple choice NAPLEX/PSAP format 
 
 
Merged classes:  for certain classes, B.S. students will merge with the P.D. students, denoted 
as “joint”- this does not affect P.D. time or location of class. 
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Integrated Studies Phar 571 
 
Monday  0910-1100 SB 111 Macklin 
Monday  0910-1100 SB 215 Allington 
Wednesday 0910-1100 SB 215 Rivey 
Wednesday 0910-1100 SB 335 Allington 
Wednesday 0910-1100 SB 337 Macklin 
 
I. Conference topics 
 
week of: 
September  3M  No conference 
 
  10M  Liver disease case 
 
  17M  Renal Disease case 
 
  24M  Headache/pain management 
 
October  1M  J-club for ½ of class; service learning project worksession 
 
   8M  Arthritis case 
 
  15M  OTC cases 
 
  22M  Contraception 
 
  29M  service learning update: J-club for other ½ of class 
 
November  5M  SEMINARS 
   
  12M  OAD case 
 
  19M  off week- holiday week 
 
  26M  TED case 
 
December  3M  OTC cases 
 
  11M  Evaluation/Diabetes case 
 
 
Seminar:  A required activity in the course, graded on a pass/no-pass basis.  Student must 
repeat a no-pass seminar to successfully pass course. 
 
